Back to mobile site

Endologix (ELGX) Misses Q4 EPS by 6c

February 22, 2016 4:06 PM EST

Endologix (NASDAQ: ELGX) reported Q4 EPS of ($0.22), $0.06 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $39.2 million versus the consensus estimate of $39.97 million.

For earnings history and earnings-related data on Endologix (ELGX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings